发明授权
- 专利标题: Moringa extract
-
申请号: US15770620申请日: 2016-10-21
-
公开(公告)号: US10441618B2公开(公告)日: 2019-10-15
- 发明人: Kazuhiko Sugiura , Aditya Kulkarni
- 申请人: Kazuhiko Sugiura , Aditya Kulkarni
- 申请人地址: JP Yokkaichi-shi
- 专利权人: TAIYO KAGAKU CO., LTD.
- 当前专利权人: TAIYO KAGAKU CO., LTD.
- 当前专利权人地址: JP Yokkaichi-shi
- 代理机构: Birch, Stewart, Kolasch & Birch, LLP
- 优先权: JP2015-211780 20151028; JP2015-211781 20151028; JP2015-247740 20151218
- 国际申请: PCT/JP2016/081237 WO 20161021
- 国际公布: WO2017/073473 WO 20170504
- 主分类号: A61K36/18
- IPC分类号: A61K36/18 ; A61K36/185 ; A23L2/52 ; A23G3/34 ; A23G4/00 ; A23L33/105 ; A23L9/10 ; A23F5/46 ; A23G3/48 ; A23G4/06 ; A23G9/42 ; A23L2/54 ; A61K31/7034 ; A23G1/48 ; A23G3/36 ; A23L2/39
摘要:
A moringa extract containing a benzyl glucosinolate in a content of 6% by mass or more, calculated as a dry solid content of the extract, wherein the extract does not substantially contain an alkaloid. The moringa extract of the present invention for solving a first aspect is useful in the field of foodstuff or the like. Also, the PPAR activator of the present invention for solving a second aspect has excellent PPAR activation action, and has no disadvantages in side effects, so that it can be ingested for long term, which can be preferably used in foodstuff and the like. Therefore, the PPAR activator of the present invention for solving a second aspect can be expected to be used as a food, a supplement or a medicament not only for prevention of disease such as insulin resistance, hyperinsulinism, Type 2 diabetes, hypertension, hyperlipidemia, arterial sclerosis and obesity, but also for fatigue recovery or endurance improvement by improving basal metabolism. In addition, a benzyl glucosinolate-containing composition for solving a third aspect is useful in the field of foodstuff or the like.
公开/授权文献
- US20180318367A1 MORINGA EXTRACT 公开/授权日:2018-11-08
信息查询